vs
Astrana Health, Inc.（ASTH）とFair Isaac（FICO）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $512.0M、Fair Isaacの約1.9倍）。Fair Isaacの純利益率が高く（30.9% vs 0.7%、差は30.2%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 16.4%）。Fair Isaacの直近四半期フリーキャッシュフローが多い（$173.9M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 8.6%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
FICO（旧社名Fair, Isaac and Company）は米国モンタナ州ボーズマンに本社を置くデータ分析企業で、1956年にビル・フェアとアール・アイザックにより創業されました。消費者の信用リスクを測定するFICOスコアは、米国の消費者融資業界で広く活用されています。
ASTH vs FICO — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $512.0M |
| 純利益 | $6.6M | $158.4M |
| 粗利率 | — | 83.0% |
| 営業利益率 | 1.9% | 45.7% |
| 純利益率 | 0.7% | 30.9% |
| 売上前年比 | 42.9% | 16.4% |
| 純利益前年比 | 184.4% | 3.8% |
| EPS（希薄化後） | $0.12 | $6.61 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $512.0M | ||
| Q3 25 | $956.0M | $515.8M | ||
| Q2 25 | $654.8M | $536.4M | ||
| Q1 25 | $620.4M | $498.7M | ||
| Q4 24 | $665.2M | $440.0M | ||
| Q3 24 | $478.7M | $453.8M | ||
| Q2 24 | $486.3M | $447.8M | ||
| Q1 24 | $404.4M | $433.8M |
| Q4 25 | $6.6M | $158.4M | ||
| Q3 25 | $373.0K | $155.0M | ||
| Q2 25 | $9.4M | $181.8M | ||
| Q1 25 | $6.7M | $162.6M | ||
| Q4 24 | $-7.8M | $152.5M | ||
| Q3 24 | $16.1M | $135.7M | ||
| Q2 24 | $19.2M | $126.3M | ||
| Q1 24 | $14.8M | $129.8M |
| Q4 25 | — | 83.0% | ||
| Q3 25 | — | 82.3% | ||
| Q2 25 | — | 83.7% | ||
| Q1 25 | — | 82.4% | ||
| Q4 24 | — | 80.1% | ||
| Q3 24 | — | 80.3% | ||
| Q2 24 | — | 80.3% | ||
| Q1 24 | — | 80.0% |
| Q4 25 | 1.9% | 45.7% | ||
| Q3 25 | 2.0% | 46.0% | ||
| Q2 25 | 3.1% | 48.9% | ||
| Q1 25 | 3.3% | 49.3% | ||
| Q4 24 | 0.1% | 40.8% | ||
| Q3 24 | 5.9% | 43.4% | ||
| Q2 24 | 6.2% | 42.5% | ||
| Q1 24 | 7.5% | 44.9% |
| Q4 25 | 0.7% | 30.9% | ||
| Q3 25 | 0.0% | 30.1% | ||
| Q2 25 | 1.4% | 33.9% | ||
| Q1 25 | 1.1% | 32.6% | ||
| Q4 24 | -1.2% | 34.7% | ||
| Q3 24 | 3.4% | 29.9% | ||
| Q2 24 | 3.9% | 28.2% | ||
| Q1 24 | 3.7% | 29.9% |
| Q4 25 | $0.12 | $6.61 | ||
| Q3 25 | $0.01 | $6.41 | ||
| Q2 25 | $0.19 | $7.40 | ||
| Q1 25 | $0.14 | $6.59 | ||
| Q4 24 | $-0.14 | $6.14 | ||
| Q3 24 | $0.33 | $5.44 | ||
| Q2 24 | $0.40 | $5.05 | ||
| Q1 24 | $0.31 | $5.16 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $162.0M |
| 総負債低いほど良い | — | $3.2B |
| 株主資本純資産 | $779.3M | $-1.8B |
| 総資産 | $2.2B | $1.9B |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $162.0M | ||
| Q3 25 | $463.4M | $134.1M | ||
| Q2 25 | $342.1M | $189.0M | ||
| Q1 25 | $260.9M | $146.6M | ||
| Q4 24 | $290.8M | $184.3M | ||
| Q3 24 | $350.3M | $150.7M | ||
| Q2 24 | $327.7M | $156.0M | ||
| Q1 24 | $337.3M | $135.7M |
| Q4 25 | — | $3.2B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.0B |
| Q4 25 | $779.3M | $-1.8B | ||
| Q3 25 | $775.5M | $-1.7B | ||
| Q2 25 | $765.5M | $-1.4B | ||
| Q1 25 | $745.4M | $-1.1B | ||
| Q4 24 | $712.7M | $-1.1B | ||
| Q3 24 | $704.6M | $-962.7M | ||
| Q2 24 | $678.9M | $-829.3M | ||
| Q1 24 | $653.5M | $-735.7M |
| Q4 25 | $2.2B | $1.9B | ||
| Q3 25 | $2.2B | $1.9B | ||
| Q2 25 | $1.4B | $1.9B | ||
| Q1 25 | $1.3B | $1.8B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | $1.3B | $1.7B | ||
| Q2 24 | $1.3B | $1.7B | ||
| Q1 24 | $1.2B | $1.7B |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $174.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $173.9M |
| FCFマージンFCF / 売上 | -0.6% | 34.0% |
| 設備投資強度設備投資 / 売上 | 0.3% | 0.0% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 1.10× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $750.6M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $174.1M | ||
| Q3 25 | $10.0M | $223.7M | ||
| Q2 25 | $90.9M | $286.2M | ||
| Q1 25 | $16.6M | $74.9M | ||
| Q4 24 | $-10.9M | $194.0M | ||
| Q3 24 | $34.0M | $226.5M | ||
| Q2 24 | $23.2M | $213.3M | ||
| Q1 24 | $6.0M | $71.0M |
| Q4 25 | $-6.0M | $173.9M | ||
| Q3 25 | $7.4M | $219.5M | ||
| Q2 25 | $89.5M | $284.4M | ||
| Q1 25 | $13.6M | $72.8M | ||
| Q4 24 | $-13.5M | $193.2M | ||
| Q3 24 | $31.7M | $224.7M | ||
| Q2 24 | $20.4M | $211.6M | ||
| Q1 24 | $5.6M | $67.0M |
| Q4 25 | -0.6% | 34.0% | ||
| Q3 25 | 0.8% | 42.6% | ||
| Q2 25 | 13.7% | 53.0% | ||
| Q1 25 | 2.2% | 14.6% | ||
| Q4 24 | -2.0% | 43.9% | ||
| Q3 24 | 6.6% | 49.5% | ||
| Q2 24 | 4.2% | 47.2% | ||
| Q1 24 | 1.4% | 15.4% |
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.5% | 0.4% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 0.6% | 0.4% | ||
| Q1 24 | 0.1% | 0.9% |
| Q4 25 | -0.44× | 1.10× | ||
| Q3 25 | 26.69× | 1.44× | ||
| Q2 25 | 9.65× | 1.57× | ||
| Q1 25 | 2.48× | 0.46× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | 2.11× | 1.67× | ||
| Q2 24 | 1.21× | 1.69× | ||
| Q1 24 | 0.40× | 0.55× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FICO
| Business To Business Scores | $248.6M | 49% |
| Saa S Products | $115.7M | 23% |
| Platform Software | $73.9M | 14% |
| Business To Consumer Scores | $55.9M | 11% |
| Technology Service | $19.2M | 4% |
